Industry/Academic Research CoI Guidelines Urged By Beckman Coulter CEO
This article was originally published in The Gray Sheet
Voluntary guidelines stipulating conflicts of interest between medical product manufacturers and academic facilities pursuing joint R&D should include a certification and inspection component, Beckman Coulter CEO John Wareham suggested Oct. 7
You may also be interested in...
Medical technology inventors should be permitted to participate as clinical trial investigators provided their interests are disclosed beforehand, AdvaMed claims in comments to an HHS proposal regulating financial conflict of interests in medical studies
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.